Stopping the progression of Alzheimer's Disease: the best hope is early diagnosis.

Alzheimer's Disease >  The first prevention study of its kind in the world, would like to recruit 500 healthy, at-risk adults.

In The Globe and Mail, Judes Poirier, helps understand the use and the limits of these games.

Team members of the Brain Imaging Centre, directed by Natasha Rajah, PhD

The goal of this study  is to understand how we can slow or reverse the emergence of AD symptoms

Contact information for the PREVENT-Alzheimer study

The goal of the PREVENT-AD program is to study memory and brain changes in healthy people over the age of 60.

Alzheimer's disease: A ticking bomb Canada and the world face a ruinous increase in the incidence of dementia caused by Alzheimer’s disease (AD). Around the globe, more than 35 million people have dementia. Their care costs $600 billion each ye

The laboratory evaluates the safety and effectiveness of an investigational drug aimed at slowing the progression of Alzheimer's Disease.

2009 Prix Coup de cœur de l'Association québécoise d'établissements de santé et services sociaux (AQESSS) Special Jury Award in recognition of its public education program Communications